 "Germany to roll out Pfizer-BioNTech coronavirus vaccine on Dec 27")
German states have been told to prepare for mass vaccinations against coronavirus starting December 27, the Berlin Senate's health authority announced Wednesday.
"Federal Health Minister Jens Spahn has informed health ministers at the conference about the pending approval and delivery of the BioNTech vaccine. This means that vaccines against the novel coronavirus SARS-CoV-2 will be rolled out in the federal states on December 27," a statement read.
The priority will be given to senior citizens in care homes, the city authority added. The European Medicines Agency, which authorises the use of new drugs across the European Union, said it would meet on December 21 to discuss whether to approve the Pfizer-BioNTech vaccine.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app